TABLE 1.

Patient characteristics

Characteristic	Ciprofloxacin group	Ciprofloxacinvancomycin group
No. of patients	41	43
Stem cell source (no. of patients)
Autologous marrow	4	5
Allogeneic marrow	9	10
Autologous peripheral stem cell	22	21
Allogeneic peripheral stem cell	6	7
Total body irradiation (no. of patients)	15	18
Primary tumor at the indicated site or disease (no. of patients)
Breast	17	14
Ovary	2	3
Sarcoma		2
Non-Hodgkin’s lymphoma	6	10
Hodgkin’s disease	1	1
Acute myelogenous leukemia	5	7
Acute lymphocytic leukemia	1	2
Chronic myelogenous leukemia	3	4
Chronic lymphocytic leukemia	2
Myeloma	2
Aplastic anemia	1
Myelodysplasia	1